newsfilter
← Latest News
Business Wire·

Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes

AspyreRx is the first FDA-authorized digital behavioral therapeutic device delivering cognitive behavioral therapy for the treatment of a cardiometabolic disease As previously reported, adding AspyreRx to standard of